Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

被引：0
|
作者：
Hiroko Masuda
Norikazu Masuda
Yoshinori Kodama
Masami Ogawa
Michiko Karita
Jun Yamamura
Kazunori Tsukuda
Hiroyoshi Doihara
Shinichiro Miyoshi
Masayuki Mano
Shoji Nakamori
Toshimasa Tsujinaka
机构：
[1] National Hospital Organization Osaka National Hospital,Department of Surgery
[2] National Hospital Organization Osaka National Hospital,Department of Pathology
[3] Okayama University Graduate School of Medicine,Department of Cancer and Thoracic Surgery
[4] Dentistry and Pharmaceutical Sciences,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Triple-negative breast cancer; Neoadjuvant chemotherapy; Pathological complete response; Ki-67; Basal-like phenotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：911 / 917
页数：6
相关论文
共 50 条
  • [1] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
  • [2] Comparison of the effectiveness of neoadjuvant chemotherapy and adjuvant chemotherapy for improving prognosis in triple-negative breast cancer patients
    Li, Wangbin
    Chang, Yuwei
    Bai, Xiaohui
    Cao, Hongxin
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3978 - 3989
  • [3] The prognosis of effectiveness neoadjuvant therapy in patients with triple-negative breast cancer
    Vyzhigina, B.
    [J]. BREAST, 2019, 44 : S67 - S67
  • [4] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [5] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    [J]. PLOS ONE, 2016, 11 (12):
  • [6] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    [J]. CANCER RESEARCH, 2015, 75
  • [7] PREDICTIVE FACTORS FOR EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCERS
    Masuda, H.
    Masuda, N.
    Kodama, Y.
    Ogawa, M.
    Karita, M.
    Yamamura, J.
    Mano, M.
    Nakamori, S.
    Thujinaka, T.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 48 - 48
  • [8] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
  • [9] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    [J]. Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [10] BRCAness and prognosis of triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
    Akashi-Tanaka, Sadako
    Tanino, Yuichi
    Yamamoto, Yutaka
    Nishimiya, Hiroshi
    Yamamoto-ibusuki, Mutsuko
    Iwase, Hirotaka
    Nakamura, Seigo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345